Innoforce Pharmaceuticals Funding: $120M Raised, Series A

Innoforce Pharmaceuticals is based in Hangzhou, Zhejiang, China. It has raised $120M in total funding. Latest round: Series A.

Innoforce Pharmaceuticals funding overview

Innoforce Pharmaceuticals is based in Hangzhou, Zhejiang, China. Innoforce Pharmaceuticals has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in March 2021. The round record for Innoforce Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include South China Venture Capital, Yanchuang Capital, Quan Capital Management, Advantech Capital, CICC Capital Management. 5 distinct backers are named across the disclosed rounds.

Innoforce Pharmaceuticals at a glance

Total raised
$120M
Latest round
Series A
Latest round date
March 2021
Headquarters
Hangzhou, Zhejiang, China
Notable investors
South China Venture Capital, Yanchuang Capital, Quan Capital Management, Advantech Capital, CICC Capital Management

Frequently asked about Innoforce Pharmaceuticals funding

How much has Innoforce Pharmaceuticals raised?
Innoforce Pharmaceuticals has raised $120M in total disclosed funding across the rounds on record.
Who has invested in Innoforce Pharmaceuticals?
South China Venture Capital, Yanchuang Capital, Quan Capital Management, Advantech Capital, CICC Capital Management are named among the investors backing Innoforce Pharmaceuticals.
What was the latest Innoforce Pharmaceuticals funding round?
The most recent disclosed round is a Series A, announced in March 2021.
Where is Innoforce Pharmaceuticals based?
Innoforce Pharmaceuticals is based in Hangzhou, Zhejiang, China.
When did Innoforce Pharmaceuticals last raise?
The last disclosed Innoforce Pharmaceuticals round closed in March 2021 at Series A.

Innoforce Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Hangzhou below to benchmark round size and investor mix.

Companies related to Innoforce Pharmaceuticals (20)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades